Search by Drug Name or NDC
NDC 00591-0371-01 Loxapine 25 mg/1 Details
Loxapine 25 mg/1
Loxapine is a ORAL CAPSULE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Actavis Pharma, Inc.. The primary component is LOXAPINE SUCCINATE.
MedlinePlus Drug Summary
Loxapine is used to treat the symptoms of schizophrenia (a mental illness that causes disturbed or unusual thinking, loss of interest in life, and strong or inappropriate emotions). Loxapine is in a group of medications called conventional antipsychotics. It works by decreasing abnormal excitement in the brain.
Related Packages: 00591-0371-01Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Loxapine
Product Information
| NDC | 00591-0371 |
|---|---|
| Product ID | 0591-0371_a75db571-2e63-4796-a741-29f6c0337d5f |
| Associated GPIs | 59154020200115 |
| GCN Sequence Number | 003982 |
| GCN Sequence Number Description | loxapine succinate CAPSULE 25 MG ORAL |
| HIC3 | H7U |
| HIC3 Description | ANTIPSYCHOTICS, DOPAMINE AND SEROTONIN ANTAGONISTS |
| GCN | 15561 |
| HICL Sequence Number | 001664 |
| HICL Sequence Number Description | LOXAPINE SUCCINATE |
| Brand/Generic | Generic |
| Proprietary Name | Loxapine |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Loxapine |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | CAPSULE |
| Route | ORAL |
| Active Ingredient Strength | 25 |
| Active Ingredient Units | mg/1 |
| Substance Name | LOXAPINE SUCCINATE |
| Labeler Name | Actavis Pharma, Inc. |
| Pharmaceutical Class | n/a |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA072206 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 00591-0371-01 (00591037101)
| NDC Package Code | 0591-0371-01 |
|---|---|
| Billing NDC | 00591037101 |
| Package | 100 CAPSULE in 1 BOTTLE, PLASTIC (0591-0371-01) |
| Marketing Start Date | 1988-06-15 |
| NDC Exclude Flag | N |
| Pricing Information | |
| Price Per Unit | 0.77976 |
| Pricing Unit | EA |
| Effective Date | 2024-02-21 |
| NDC Description | LOXAPINE 25 MG CAPSULE |
| Pharmacy Type Indicator | C/I |
| OTC | N |
| Explanation Code | 1 |
| Classification for Rate Setting | G |
| As of Date | 2024-02-21 |
This pricing file, entitled the NADAC (National Average Drug Acquisition
Cost) files, provide
state Medicaid agencies with covered outpatient drug prices by averaging
survey invoice
prices from retail community pharmacies across the United States. These
pharmacies include
independent retail community pharmacies and chain pharmacies. The prices
are updated on a
weekly and monthly basis